Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LT7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,642
Award facts
- Contract value 100% obligated
- $17,642.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17.6K to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pens on January 16, 2026, with completion targeted for January 20, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9M through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military treatment facilities. The company's extensive contract portfolio with the Defense Logistics Agency encompasses a broad range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This specific delivery order for Zepbound, a diabetes and weight management medication, reflects the company's role in supplying specialized pharmaceutical products essential to military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F9LT7?
SPE2DR26F9LT7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LT7 worth?
The government has obligated $17,642 on SPE2DR26F9LT7.
Is contract SPE2DR26F9LT7 an order under another contract?
Yes. SPE2DR26F9LT7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LT7 competed?
The extent of competition for SPE2DR26F9LT7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award